Stories
Prime + JDRF: A personal connection
For Kelley Loughrey, a life-threatening incident involving her son sent them straight to the hospital. But what came out of that experience is something so much more.
April 4, 2019When they got to the pediatrician’s office, Alex’s blood sugar level was checked. A normal blood sugar level is between 96-110. Alex’s was at 365. “It was that exact moment that we knew this was life-threatening,” says Kelley. “The pediatrician advised us to get to the hospital immediately.”
Alex was hospitalized for a few days at Children’s Hospital, where they continued to monitor his blood sugar levels. It was then that he was diagnosed with T1 diabetes. It was also the moment that Kelley learned about JDRF.
“I met another mom at Children’s Hospital who told me about JDRF,” says Kelley. “I got excited and wanted to learn more. I started volunteering for JDRF and eventually got on the Board of Directors.” In 2018, while serving as the Board President, Kelley helped start JDRF’s Board of Chancellors and met a Prime employee who also lives with T1 diabetes. At that time, Prime had just signed on as a sponsor partner with JDRF for all of Prime’s fundraising and awareness events.
“I realized Prime was more than a PBM. They truly seemed to care about the health and wellbeing of others out there that deal with T1 diabetes through their sponsorship,” says Kelley. “I went home that night and applied for a position at Prime that I thought would be a great fit for me.” She also read about PrimeCares, where Prime supports a select number of health-related charities important to the communities in which they operate, including JDRF.
Kelley has been with Prime’s talent development team for about a year now. She enjoys her job, and her ability to continue her commitment to JDRF as a member of the Board of Chancellors. “The fact that I can work for a company that shares the same passion I do is proof that all of the stars aligned. I love seeing Prime give back and show their support. I feel truly grateful to be able to work for Prime, and I’m hopeful that together, we’ll unlock the cure for T1 diabetes someday.”
Related news
Stories
May 2, 2024
Prime discusses leading medically integrated dispensing model at Asembia
Connecting specialty pharmacies and providers to unlock optimal care and value
Stories
April 30, 2024
RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Stories
April 24, 2024
New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care
Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances